The Crick appoints Clinical Research Director

Professor Sir Peter J Ratcliffe FRS is to combine his work at Oxford University with a new role as Clinical Research Director at the Francis Crick Institute from May 2016. 
He will step down from his current role as Nuffield Professor of Clinical Medicine and Head of the Nuffield Department of Clinical Medicine but will continue to spend half his time at the University of Oxford, notably as Director of the Target Discovery Institute and the Oxford Hypoxia Biology Laboratory, and as Member of the Ludwig Institute for Cancer Research.
Professor Andy Hamilton, Vice Chancellor of Oxford University, said: 'This is excellent news for biomedical research in the UK. Sir Peter has done great work as the head of the Nuffield Department of Clinical Medicine and in his research into low oxygen levels, an important component of many diseases. Now, his new roles at the Crick Institute and the University of Oxford will be complementary, developing relationships across the UK biomedical research community.
'I am also pleased that Sir Peter will retain a contract with the Oxford University Hospitals NHS Foundation Trust, ensuring that his expertise will continue to support patients in Oxfordshire. Together, these appointments reflect what we strive to achieve - world-leading science enabled by cooperation and collaboration across organisations, delivering benefits for patients.'
Sir Paul Nurse, Director of the Francis Crick Institute, said: 'Sir Peter is a clinical scientist of the highest quality and I am delighted that he has agreed to join the Crick as our inaugural Clinical Research Director.  Developing a culture of experimental medicine is a critical element of the Crick's StrategyDiscovery Without Boundaries, enabling us to explore the opportunities for human physiological processes to inform basic biological models and vice versa.  To be effective we will need to attract the very best clinical researchers across all career stages, and having a leader of Peter's stature and reputation will assist greatly in this.'
Sir Peter said 'I am honoured and delighted by this appointment and the opportunities it provides to promote the Francis Crick Institute's impact on biomedical discovery across the UK and beyond. The dual position will also enable me to maintain and progress a number of initiatives in biomedical research that began in Oxford, and provides an excellent platform to develop this exciting role.'
Sir Peter Ratcliffe will continue as the Head of Department at NDM until the end of April 2016, allowing time for a successor to be appointed. 

Sign up for our newsletters

Join our mailing lists to receive updates about our latest research and to hear about our free public events and exhibitions.  If you would like to find out more about how we manage your personal information please see our privacy policy.